Oncolytics Biotech
ONCY----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Oncolytics Biotech(ONCY) predict that the EBIT is -9.15 M (-87.16%), Miss estimate;the EPS is -0.0789 (-41.15%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B87.16%
-0.01B16.09%
-0.00B71.07%
EPSMiss expectations
-0.078941.15%
-0.048113.93%
-0.030855.08%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf